FDA finds low levels of possible carcinogen in Zantac
The FDA announced Friday that it found low levels of a possible carcinogen in Zantac and other heartburn medications.
The FDA announced Friday that it found low levels of a possible carcinogen in Zantac and other heartburn medications.